• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

System for cataract surgery nets positive initial outcomes


Intra-operative use of on-screen image guidance with a high-definition three-dimensional surgical microscope system is showing promise for improving the precision and predictability of various maneuvers during small-incision cataract surgery.

Dr. Weinstock presented preliminary results from an ongoing FDA 510(k) trial that is investigating use of the template system for guidance in capsulorhexis creation and for limbal relaxing incisions (LRIs). A template system for guiding toric IOL alignment also is being developed.

Data from 11 eyes where a template for capsulorhexis was used showed the achieved capsulorhexis diameter matched the intended target (=6 mm) in all cases. Results from a 6-week follow-up visit were available for 22 eyes that underwent LRIs.

"Use of this guidance software in cataract surgery has the potential to improve safety and efficacy outcomes and, in particular, optimize refractive results and reduce complication rates," he said. "Ongoing FDA trials of this investigational technology are measuring outcomes directly and will establish whether this system has benefit for surgeons and our patients."

Several components

The surgical system has several components, including a 3-D high-definition camera (TrueZoom 3D Surgical Camera) that mounts to the operating microscope. A beam splitter sends the images to a workstation that interprets the input and creates a 3-D high-definition video display on a widescreen monitor. The surgeon operates in a heads-up position, wearing 3-D glasses to view a real-time display of the surgical field on the monitor.

"I have personal experience operating on [more than] 2,000 cases directly from this 3-D HD video display and find the system offers improved depth of field relative to conventional microscope oculars along with an ergonomic advantage from being able to operate with upright posture," Dr. Weinstock said.

For the guidance system, templates are created using preoperative high-definition 3-D photos obtained at a 3-D digital slit-lamp microscope and case-specific surgical parameters, i.e., capsulorhexis size, shape, and location or the location and length of LRIs. The slit-lamp images are imported into the operating room digital visualization system, and the templates generated by the software appear as a screen overlay on the monitor display of the surgical field.

Accurate placement of the template is achieved by aligning the image with the live eye view. Alignment is verified using limbal blood vessels, and then iris registration of the preoperative image to the live eye view combined with intraoperative tracking assures the alignment is maintained, even if the eye moves.

"The surgeon creates the capsulorhexis by tearing along the outline on the template or performs the LRIs by literally using the blade to trace along the lines appearing on the screen," Dr. Weinstock said.

He also reported the findings from a retrospective analysis of data collected using the 3-D high-definition surgical microscope system that indicated benefits compared with operating through conventional microscope oculars.

Using the 3-D system in a series of 293 eyes, the rate of posterior capsule tearing was 0.35% versus 1.09% in a cohort of 461 cases performed using conventional microscope oculars. Use of the 3-D system was associated with a 2.7% reduction in surgical time.

"Clearly, both technologies are safe and effective in routine cases, but these early data support [that] there may be some safety benefits from operating with a heads-up system," he said.


Robert J. Weinstock, MDE-mail: rjweinstock@yahoo.com

Dr. Weinstock is a consultant to and investor in TrueVision.

© 2024 MJH Life Sciences

All rights reserved.